Therapeutic, regulatory, and commercial depth across global markets
Editors and analysts with pharma, regulatory, and market backgrounds
Editor-in-Chief
Former IQVIA
Expertise Regulatory Affairs · Editorial Strategy · Oncology
15+ years in pharma
15 years in pharmaceutical publishing and editorial strategy, covering drug development, oncology pipelines, and regulatory affairs.
Managing Editor
Former Reuters Health
Expertise FDA Approvals · Biotech · Breaking News
14+ years in pharma
Journalist specializing in FDA approvals and biotech coverage. Previously covered pharma and biotech for Reuters Health.
Regulatory Affairs Editor
Former Pfizer
Expertise FDA · EMA · Global Pathways
12+ years in pharma
Writes on FDA, EMA, and global regulatory pathways, translating submissions, approvals, and guidance into actionable intelligence.
Senior Science Editor
Former Genentech
Expertise Immunotherapy · Oncology · Science Writing
11+ years in pharma
Science editor covering oncology, immunotherapy, and mechanism-of-action explainers for a professional pharma audience.
Market Analysis Editor
Former McKinsey
Expertise Market Access · Pricing · Competitive Intel
8+ years in pharma
Covers pharmaceutical market dynamics, pricing, market access, and competitive intelligence.
All content is reviewed by regulatory, scientific, and industry specialists before publication. AI-assisted analysis is validated by human pharmaceutical experts.
Our methodology combines regulatory monitoring, conference intelligence, research library analysis, and editorial validation — positioning NovaPharmaNews closer to institutional intelligence than media blogging.
